TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event

Momentum & Trend

Power Trend

1,667 Hits · last calculated November 4, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · showing the 100 strongest hits

Methodology & criteria

Minervini/Qullamaggie Power Trend: the daily low has stayed above the 21-day EMA for at least 10 days, the 21-EMA has been above the 50-day SMA for at least 5 days, and the 50-SMA is rising — the condition in which trend traders are fully invested. When the Power Trend ends, they reduce risk.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(16)
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Scanners that run without the global filters still include them; that is noted below their hit list. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EMA (Exponential Moving Average)
Like the simple moving average, but more recent prices carry more weight - the line follows price faster. The 21-day EMA is the standard short-term trend line for momentum traders.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run. The cap does not apply to scanners that run without the global filters; that is noted below their hit list.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
SMA / Moving Average (10-, 20-, 50-, 200-Day Line)
The average price of the last X days, plotted as a line on the chart (Simple Moving Average). The 50-day and 200-day lines are the most closely watched: price above the line = uptrend intact. The 30-week line from the Weinstein method corresponds to the 150-day line.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.

View all terms in the Scanner Glossary

Hit List

Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

Power Trend
Symbol Earnings Avg/Y 3Y Volatility Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
ANRO Alto Neuroscience, Inc. 08/12 — 76 % Stage 2 D 31 2 of 9 0.8 $ Biotechnology – — — Healthcare 22.70 $ +37.3 % +41.2 % +56.4 % −11.0 % +66.0 % 99 42 8.0 % 7.7 % 1.34 — 0.0 — 3.4 — — 0.0 — — 0.0 % -38.9 % -26.8 % 0.02 — -100.0 % 2 0.0 % 0.0 % 12.7 82.1 % 13.9 % 4.8 (11)
CLYM Climb Bio Inc 11/05 +142 % ⚠ Wildest 10% 93 % Stage 2 D 35 3 of 9 0.6 $ Biotechnology – — — Healthcare 9.80 $ +207.5 % +175.5 % +375.1 % −5.9 % +175.9 % 99 42 7.3 % 8.2 % -0.03 — 0.0 — 4.0 — — 0.6 — — 0.0 % -30.9 % -18.5 % 0.00 — — 2 0.0 % 0.0 % 35.4 66.5 % 23.9 % 4.9 (16)
WULF Terawulf Inc 08/14 +500 % ⚠ Wildest 10% 92 % Stage 2 D 32 2 of 9 6.3 $ Capital Markets – — — Financial Services 12.50 $ +150.5 % +107.8 % -29.4 % −12.7 % +139.7 % 98 42 8.4 % 8.3 % 4.25 — 769.2 38.0 36.7 — — 75.5 -366.2 % 69.3 % 0.0 % -2,216.0 % -4.8 % -67.46 -1.1 % +20.3 % 4 0.0 % 0.0 % 2.8 82.5 % 30.2 % 4.7 (25)
PRAX Praxis Precision Medicines Inc 08/03 +177 % 72 % Stage 2 C 54 4 of 9 7.8 $ Biotechnology – — — Healthcare 280.50 $ +3.6 % +27.6 % +37.9 % −10.6 % +127.7 % 98 42 6.8 % 7.0 % 2.81 — 0.0 — 5.5 — — -6.9 0.0 % -3,895.3 % 0.0 % -35.3 % -25.7 % 0.00 96.6 % -100.0 % 3 0.0 % 0.0 % 31.8 116.8 % 15.0 % 4.5 (21)
KOD Kodiak Sciences Inc 08/12 +137 % ⚠ Wildest 10% 136 % Stage 2 D 29 2 of 9 6.2 $ Biotechnology – — — Healthcare 98.90 $ +32.5 % +21.4 % +438.6 % −28.7 % +25.4 % 98 42 8.0 % 7.7 % 2.04 — 0.0 — — — — -0.1 0.0 % — 0.0 % -208.8 % -60.5 % — 36.6 % — 4 0.0 % 0.0 % -15.7 99.6 % 23.6 % 4.6 (7)
BAND Bandwidth Inc 10/29 +106 % ⚠ Wildest 10% 97 % Stage 2 B 60 7 of 9 1.4 $ Software - Infrastructure Sells AI
Read
— Technology 43.40 $ +241.3 % +304.3 % +166.1 % −31.1 % +37.1 % 98 42 8.6 % 8.7 % 3.01 — 23.0 1.6 3.0 14.1 — 31.6 -2.2 % 37.2 % 0.3 % -1.4 % -0.9 % 1.04 41.2 % +0.7 % 3 0.0 % 0.0 % 3.6 80.1 % 17.2 % 3.9 (7)
SLS Sellas Life Sciences Group Inc 08/11 +148 % ⚠ Wildest 10% 107 % Stage 2 B 58 3 of 9 1.8 $ Biotechnology Uses AI
Read
— Healthcare 8.90 $ +140.6 % +444.0 % +369.8 % −4.8 % +235.1 % 98 50 12.4 % 11.1 % 2.57 — 0.0 — — — — -1.7 0.0 % — 0.0 % -43.6 % -23.3 % — 94.1 % -100.0 % 1 0.0 % 0.0 % 16.0 27.6 % 26.7 % 4.5 (2)
ATROB Astronics Corp Cl B 07/30 +130 % 81 % Stage 2 B 69 6 of 9 2.7 $ Aerospace & Defense – — — Industrials 61.00 $ +81.9 % +204.6 % +38.7 % −9.8 % — 98 50 9.3 % 6.4 % 1.25 73.0 47.2 2.9 22.7 40.9 1.47 20.4 — 32.3 % 8.4 % 21.2 % 11.2 % 2.34 — +8.4 % 5 0.0 % 0.0 % 7.9 11.0 % — —
ARTV Artiva Biotherapeutics, Inc. 08/05 — ⚠ Wildest 10% 125 % Stage 2 D 33 2 of 9 0.2 $ Biotechnology – — — Healthcare 4.20 $ +128.4 % +122.8 % +0.5 % −39.2 % +477.4 % 98 42 10.4 % 10.4 % 2.41 — 0.0 — 2.5 — — 0.0 — — 0.0 % -67.9 % -22.3 % 0.12 — -100.0 % 3 0.0 % 0.0 % -3.3 51.3 % 9.3 % 4.8 (6)
WYY WidePoint Corporation 08/13 +242 % ⚠ Wildest 10% 116 % Stage 2 B 58 5 of 9 0.1 $ Information Technology Services – — — Technology 7.00 $ +184.4 % +194.6 % +7.5 % −16.9 % +322.5 % 98 13 16.8 % 12.9 % 1.84 — 5.3 0.4 — 15.3 2.33 38.1 — 14.2 % -0.8 % -15.8 % -1.0 % — — +5.6 % 6 0.0 % 0.0 % -0.1 18.7 % 5.0 % 4.5 (2)
RVMD Revolution Medicines Inc 08/05 +188 % 62 % Stage 2 D 31 1 of 9 40.4 $ Biotechnology – — — Healthcare 194.20 $ +112.8 % +137.2 % +227.4 % −3.4 % +39.0 % 97 42 4.8 % 4.4 % 1.40 — 0.0 — 27.7 — — -9.7 0.0 % -174,708.6 % 0.0 % -76.7 % -30.1 % 0.29 66.6 % -100.0 % 2 0.0 % 0.0 % 1.4 95.7 % 5.9 % 4.7 (25)
KLIC Kulicke and Soffa Industries Inc 08/05 +47 % 59 % Stage 2 A 77 6 of 9 3.8 $ Semiconductor Equipment & Materials Neutral
Read
— Technology 72.40 $ +180.3 % +179.3 % +80.5 % −1.4 % +26.4 % 97 6 7.6 % 6.8 % 1.56 65.6 11.2 4.0 4.4 95.0 2.38 21.6 15.9 % 49.3 % 12.2 % 6.4 % 7.4 % 0.05 72.3 % -7.4 % 4 1.1 % 31.5 % 13.9 93.1 % 5.1 % 3.3 (3)
RLAY Relay Therapeutics Inc 08/06 +16 % 64 % Stage 2 D 29 3 of 9 3.8 $ Biotechnology – — — Healthcare 17.40 $ +106.1 % +128.2 % +142.0 % −5.9 % +40.0 % 97 42 6.4 % 8.1 % 1.73 — 0.0 361.9 — — — -0.8 -2,619.7 % -2,497.6 % 0.0 % -40.0 % -22.9 % — 91.8 % +53.4 % 5 0.0 % 0.0 % 8.5 87.0 % 24.8 % 4.8 (13)
BFLY Butterfly Network Inc 08/07 +88 % ⚠ Wildest 10% 113 % Stage 2 B 62 3 of 9 1.6 $ Medical Devices – — — Healthcare 6.40 $ +101.8 % +125.6 % +128.3 % −10.3 % +43.2 % 97 42 15.1 % 10.2 % 2.04 — 0.0 12.9 8.6 — — -9.6 -50.8 % 68.2 % -66.8 % -35.2 % -10.5 % 0.10 66.9 % +19.0 % 5 0.0 % 0.0 % -2.4 55.8 % 15.7 % 4.9 (7)
MBX MBX Biosciences, Inc. 08/06 — 76 % Stage 2 D 34 3 of 9 2.5 $ Biotechnology Neutral
Read
— Healthcare 55.00 $ +47.1 % +67.7 % +147.7 % −4.1 % +76.6 % 97 42 8.5 % 7.7 % 0.10 — 0.0 — 6.0 — — 0.0 0.0 % — 0.0 % -25.7 % -22.1 % 0.00 96.7 % — 2 0.0 % 0.0 % 37.2 111.5 % 13.0 % 4.7 (11)
ATEX Anterix Inc 08/11 +51 % 64 % Stage 2 B 66 7 of 9 1.6 $ Telecom Services Neutral
Read
— Communication Services 82.20 $ +266.4 % +339.9 % +306.6 % −8.1 % +27.7 % 97 85 8.3 % 8.2 % 0.89 19.4 0.0 215.7 7.0 106.4 — -12.4 — 100.0 % 933.0 % 43.3 % -5.9 % 0.02 — +7.8 % 6 0.0 % 0.0 % 3.5 91.8 % 13.7 % 4.0 (3)
BIOA BioAge Labs, Inc 08/05 — ⚠ Wildest 10% 130 % Stage 2 C 48 4 of 9 0.3 $ Drug Manufacturers - Specialty & Generic – — — Healthcare 6.00 $ +68.7 % +77.2 % -23.4 % −9.3 % +551.1 % 97 50 8.5 % 7.7 % 1.08 — 0.0 25.6 0.8 — — 0.0 — -747.8 % 0.0 % -26.0 % -18.5 % 0.01 — -100.0 % 3 0.0 % 0.0 % 26.5 85.5 % 8.0 % 4.2 (10)
APLD Applied Digital Corporation 07/29 +153 % ⚠ Wildest 10% 102 % Stage 2 C 52 5 of 9 5.2 $ Information Technology Services Sells AI
Read
— Technology 17.80 $ +84.6 % +46.9 % -53.2 % −19.3 % +206.1 % 96 42 8.8 % 9.9 % 6.00 — 526.3 — 2.9 — 1.83 -7.4 -20.5 % 21.7 % -53.0 % -5.6 % -2.0 % 1.79 25.3 % +57.7 % 5 0.0 % 0.0 % 4.7 71.9 % 23.9 % 4.6 (16)
APGE Apogee Therapeutics, Inc. 08/10 — 63 % Stage 2 D 37 4 of 9 10.1 $ Biotechnology – — — Healthcare 135.10 $ +76.0 % +69.8 % +254.0 % −0.4 % -0.4 % 96 42 6.7 % 6.5 % 0.33 — 0.0 — 8.1 — — 0.0 0.0 % — 0.0 % -28.5 % -20.3 % 0.01 97.1 % — 3 0.0 % 0.0 % 40.3 131.6 % 7.3 % 5.0 (9)
TVTX Travere Therapeutics Inc 08/05 +82 % 60 % Stage 2 C 53 5 of 9 4.5 $ Biotechnology Uses AI
Read
— Healthcare 49.40 $ +46.4 % +44.7 % +40.1 % −1.8 % +48.1 % 96 42 3.6 % 4.6 % 1.14 — 33.3 6.9 44.9 29.2 — 836.8 -29.0 % 59.2 % -7.4 % -69.4 % -3.7 % 3.35 17.8 % +110.5 % 6 0.0 % 0.0 % -2.7 113.4 % 15.1 % 4.7 (15)
CELC Celcuity LLC 08/13 +65 % 65 % Stage 1 D 40 2 of 9 3.5 $ Biotechnology Neutral — — Healthcare 69.70 $ -9.6 % -0.1 % -13.1 % −36.5 % +122.6 % 96 42 5.5 % 7.2 % 0.11 — 0.0 — — — — -7.8 0.0 % — 0.0 % -275.2 % -25.8 % — 13.1 % — 4 0.0 % 0.0 % 2.6 101.2 % 31.4 % 4.8 (13)
DNTH Dianthus Therapeutics Inc. 08/06 +247 % 60 % Stage 2 D 39 4 of 9 4.5 $ Biotechnology – — — Healthcare 82.70 $ +112.4 % +121.7 % +135.1 % −5.1 % +68.8 % 96 50 5.9 % 6.6 % 0.18 — 0.0 — — — — -7.3 -10,050.3 % 100.0 % 0.0 % -22.7 % -17.7 % — 96.4 % -67.4 % 4 0.0 % 0.0 % 35.6 120.4 % 18.4 % 4.9 (18)
GLUE Monte Rosa Therapeutics Inc 08/06 +19 % 78 % Stage 2 D 36 4 of 9 0.9 $ Biotechnology Uses AI
Read
— Healthcare 10.40 $ +32.1 % +35.5 % -17.3 % −16.0 % +148.8 % 96 50 8.1 % 6.8 % 1.37 — 10.0 30.6 1.6 — — 9.5 — -465.2 % 0.0 % -32.6 % -21.6 % 0.08 — +63.5 % 4 0.0 % 0.0 % 7.7 113.2 % 24.6 % 4.8 (10)
TH Target Hospitality Corp. 08/06 +18 % 64 % Stage 2 D 43 4 of 9 1.4 $ Specialty Business Services Sells AI
Read
— Industrials 14.50 $ +101.6 % +110.8 % +77.0 % −21.3 % +78.7 % 96 12 4.0 % 4.1 % 1.49 — 16.8 4.2 3.4 11.3 1.12 35.3 -19.7 % 31.9 % -10.9 % -11.0 % -3.7 % 0.02 73.4 % -17.0 % 3 0.0 % 0.0 % 8.0 78.5 % 12.3 % 4.8 (5)
IRWD Ironwood Pharmaceuticals Inc 11/05 -22 % ⚠ Wildest 10% 83 % Stage 2 B 65 6 of 9 0.6 $ Drug Manufacturers - Specialty & Generic Neutral
Read
— Healthcare 3.50 $ +14.5 % +31.9 % +80.2 % −33.6 % +69.4 % 96 97 6.0 % 6.0 % 0.22 6.2 12.3 1.5 2.4 3.1 — 3.7 — 77.2 % 33.4 % -574.7 % 47.0 % -2.75 — -15.7 % 5 0.0 % 0.0 % -4.7 98.9 % 10.3 % 3.8 (4)
BLZE Backblaze Inc 08/06 +57 % ⚠ Wildest 10% 106 % Stage 3 B 65 5 of 9 0.5 $ Software - Infrastructure Uses AI
Read
— Technology 8.40 $ +150.2 % +211.9 % -28.2 % −8.2 % +150.9 % 96 42 14.6 % 9.7 % 1.57 — 54.3 2.9 — 18.4 — 58.4 — 62.3 % -13.1 % -27.6 % -3.5 % — — +14.3 % 5 0.0 % 0.0 % -0.3 48.9 % 12.1 % 4.4 (7)
DWSN Dawson Geophysical Company 08/11 +12 % ⚠ Wildest 10% 125 % Stage 2 B 60 5 of 9 0.1 $ Oil & Gas Equipment & Services – — — Energy 1.70 $ +192.9 % +232.9 % -13.2 % −2.0 % +100.0 % 96 96 9.5 % 10.2 % 0.11 — 3.8 0.5 — — 12.17 6.3 — 22.3 % 3.5 % 22.7 % 6.6 % — — +2.0 % 2 0.0 % 0.0 % -2.2 86.1 % 3.1 % —
IMMX Immix Biopharma Inc 08/14 +93 % ⚠ Wildest 10% 83 % Stage 2 D 40 5 of 9 0.5 $ Biotechnology – — — Healthcare 7.70 $ +89.5 % +82.8 % +91.1 % −16.3 % +212.3 % 96 42 9.2 % 8.4 % 0.24 — 0.0 — 6.9 — — -0.4 — — 0.0 % -74.5 % -20.5 % 0.01 — — 3 0.0 % 0.0 % 10.2 45.1 % 15.2 % 4.6 (7)
MGNX MacroGenics Inc 08/13 -6 % ⚠ Wildest 10% 92 % Stage 2 C 53 5 of 9 0.1 $ Biotechnology – — — Healthcare 2.30 $ +191.3 % +200.0 % +40.4 % −8.3 % +233.3 % 96 8 8.1 % 7.0 % 1.21 — 61.0 0.9 — — 0.01 -1.5 — -0.7 % -8.3 % -140.3 % -8.1 % — — +0.8 % 3 0.0 % 0.0 % -15.0 70.3 % 11.5 % 3.7 (7)
RIOT Riot Platforms, Inc. 07/30 +49 % ⚠ Wildest 10% 87 % Stage 2 D 36 2 of 9 5.3 $ Capital Markets Sells AI
Read
— Financial Services 14.00 $ +126.4 % +99.4 % -40.1 % −8.4 % +105.8 % 95 74 7.9 % 7.5 % 3.76 — 20.9 7.9 2.1 — — 34.9 -280.5 % 28.3 % -196.3 % -32.5 % -21.2 % 0.39 69.7 % +71.9 % 3 0.0 % 0.0 % 3.1 81.6 % 15.5 % 4.6 (22)
COGT Cogent Biosciences Inc 08/04 +12 % ⚠ Wildest 10% 91 % Stage 1 C 46 4 of 9 5.2 $ Biotechnology – — — Healthcare 31.10 $ +2.2 % -2.5 % +82.4 % −13.1 % +73.3 % 95 42 4.5 % 4.5 % 0.31 — 0.0 — 9.5 — — -3.9 0.0 % — 0.0 % -85.7 % -43.8 % 0.39 67.3 % -100.0 % 3 0.0 % 0.0 % 4.1 112.3 % 11.3 % 4.7 (12)
SPHR Sphere Entertainment Co. 08/06 +158 % 54 % Stage 2 C 51 9 of 9 3.1 $ Entertainment Uses AI
Read
— Communication Services 105.10 $ +66.4 % +83.4 % +53.3 % −0.4 % +43.6 % 95 50 4.7 % 4.8 % 1.60 45.4 28.4 2.2 2.1 8.2 — 23.1 2.7 % 54.7 % -5.7 % 5.5 % -1.3 % 0.42 53.2 % +0.0 % 5 0.0 % 0.0 % 4.9 130.0 % 36.5 % 4.4 (13)
ATRO Astronics Corporation 08/05 +154 % 55 % Stage 2 B 64 6 of 9 3.0 $ Aerospace & Defense Neutral
Read
— Industrials 60.90 $ +91.0 % +94.2 % +52.7 % −12.8 % +61.7 % 95 89 6.0 % 5.8 % 1.25 — 46.9 3.2 — 44.3 1.46 19.5 11.8 % 32.3 % 8.4 % 21.2 % 11.2 % — 21.6 % +8.4 % 4 0.0 % 0.0 % 7.9 101.1 % 9.2 % 4.4 (5)
ELVN Enliven Therapeutics Inc. 08/12 +44 % 71 % Stage 2 D 32 4 of 9 3.0 $ Biotechnology – — — Healthcare 44.80 $ +215.6 % +203.9 % +90.6 % −2.8 % +66.1 % 95 42 6.6 % 6.9 % 0.34 — 0.0 — 7.2 — — -6.3 0.0 % — 0.0 % -26.6 % -11.0 % 0.00 97.5 % — 2 0.0 % 0.0 % 47.0 89.7 % 20.4 % 4.8 (14)
CAPR Capricor Therapeutics Inc 08/10 +8 % ⚠ Wildest 10% 217 % Stage 2 D 27 3 of 9 2.0 $ Biotechnology Neutral
Read
— Healthcare 8.20 $ +2.6 % -19.8 % +11.2 % −24.7 % +335.5 % 95 42 7.5 % 5.7 % 0.61 — 78.7 — — — 0.38 -2.7 0.0 % -896.1 % 0.0 % -56.4 % -33.6 % — 85.4 % -100.0 % 2 0.0 % 0.0 % 8.7 59.7 % 35.8 % 3.7 (10)
VSTS Vestis Corporation 08/04 — 55 % Stage 2 C 50 8 of 9 1.9 $ Rental & Leasing Services – — — Industrials 14.60 $ +97.9 % +120.0 % +179.6 % −2.0 % -15.0 % 95 3 3.9 % 4.3 % 1.07 — 0.0 0.7 — 12.4 — 14.6 4.2 % 26.3 % -0.2 % -2.0 % 2.5 % — 30.2 % -2.5 % 4 0.0 % 175.0 % 4.9 101.7 % 11.7 % 3.0 (8)
APPS Digital Turbine Inc 08/04 -13 % ⚠ Wildest 10% 95 % Stage 2 B 69 6 of 9 1.1 $ Software - Application Uses AI
Read
— Technology 9.20 $ +85.2 % +140.0 % +35.6 % −5.9 % +71.7 % 95 17 10.7 % 12.7 % 3.03 — 14.1 1.9 — 53.2 0.69 13.7 — 49.1 % -5.8 % -21.8 % 4.7 % — — +15.2 % 5 0.0 % 0.0 % 0.9 66.7 % 9.9 % 4.8 (4)
NVCT Nuvectis Pharma Inc 08/04 +1 % ⚠ Wildest 10% 86 % Stage 2 D 29 1 of 9 0.6 $ Biotechnology – — — Healthcare 19.30 $ +132.5 % +270.0 % +185.8 % −0.2 % +85.3 % 95 42 16.4 % 9.8 % -0.24 — 0.0 — — — — -7.4 — — 0.0 % -154.4 % -73.1 % — — -100.0 % 3 0.0 % 0.0 % -7.1 18.2 % 11.1 % 4.7 (6)
ZNTL Zentalis Pharmaceuticals Llc 08/05 -29 % ⚠ Wildest 10% 118 % Stage 2 E 24 2 of 9 0.1 $ Biotechnology – — — Healthcare 1.80 $ +172.6 % +234.1 % +23.3 % −45.5 % +272.2 % 95 42 8.9 % 7.8 % 1.94 — 0.0 — — — — -2.3 — 100.0 % 0.0 % -51.9 % -33.2 % — — -100.0 % 3 0.0 % 0.0 % -8.6 62.1 % 7.1 % 4.5 (11)
SNX Synnex Corporation — +71 % 36 % Stage 2 B 63 5 of 9 18.4 $ Electronics & Computer Distribution Sells AI
Read
— Technology 228.00 $ +94.2 % +77.4 % +50.1 % −6.4 % +33.3 % 94 86 4.3 % 4.0 % 1.37 15.2 9.8 0.2 2.0 — 0.49 9.8 2.7 % 6.9 % 1.8 % 11.7 % 3.5 % 0.23 23.2 % +6.9 % 4 0.8 % 10.2 % 5.1 95.7 % 2.6 % 4.5 (11)
OSCR Oscar Health Inc 08/05 +84 % 66 % Stage 2 B 64 7 of 9 9.3 $ Healthcare Plans Uses AI — — Healthcare 32.40 $ +108.3 % +97.3 % +72.2 % −5.6 % +19.3 % 94 87 5.6 % 6.6 % 2.47 — 588.2 0.6 6.2 2.1 — 0.0 15.2 % 20.2 % 3.6 % -2.6 % 4.5 % 0.26 17.9 % +27.5 % 4 0.0 % 0.0 % 3.0 67.6 % 7.2 % 3.2 (11)
XMTR Xometry Inc 08/04 +114 % ⚠ Wildest 10% 83 % Stage 2 B 67 5 of 9 6.1 $ Industrial Distribution – — — Industrials 111.30 $ +54.3 % +48.6 % +96.1 % −7.3 % +12.3 % 94 42 4.8 % 5.7 % 1.23 — 81.3 7.6 20.8 — — -13.1 -2.5 % 38.8 % -3.8 % -17.5 % -2.2 % 1.21 38.1 % +25.9 % 5 0.0 % 0.0 % 3.0 96.4 % 8.0 % 4.3 (12)
IRDM Iridium Communications Inc 07/23 -8 % 58 % Stage 2 C 53 6 of 9 4.6 $ Telecom Services Neutral
Read
— Communication Services 43.90 $ +156.4 % +216.6 % +133.1 % −22.3 % +4.6 % 94 21 9.0 % 8.0 % 0.85 45.3 22.6 5.1 10.1 16.7 1.74 14.9 23.2 % 71.5 % 18.1 % 21.4 % 3.8 % 4.77 18.5 % +4.9 % 6 1.4 % 43.1 % 4.1 90.1 % 3.7 % 3.7 (7)
IBRX Immunitybio Inc 08/04 +57 % ⚠ Wildest 10% 102 % Stage 2 C 50 3 of 9 8.6 $ Biotechnology Uses AI
Read
— Healthcare 8.30 $ +269.7 % +309.8 % +231.3 % −37.3 % +61.9 % 94 42 7.8 % 7.0 % 0.03 — 78.1 51.7 — — — -9.0 -157.9 % 99.3 % 0.0 % 0.0 % -30.5 % — -134.5 % +668.3 % 6 0.0 % 0.0 % -23.1 17.6 % 30.7 % 4.8 (4)
NESR National Energy Services Reunited Corp. 08/19 +252 % 58 % Stage 2 B 69 7 of 9 2.1 $ Oil & Gas Equipment & Services Neutral
Read
— Energy 20.70 $ +60.1 % +89.1 % +66.2 % −2.6 % +87.4 % 94 87 5.7 % 5.1 % 0.48 31.0 0.0 1.3 2.0 9.0 — 7.6 8.9 % 13.3 % 5.8 % 6.7 % 4.8 % 0.31 51.7 % +1.7 % 7 0.0 % 0.0 % 5.0 85.2 % 7.6 % 4.6 (9)
URGN UroGen Pharma Ltd 08/06 +18 % 62 % Stage 2 B 63 3 of 9 1.7 $ Biotechnology Uses AI — — Healthcare 34.40 $ +50.1 % +51.8 % +67.9 % −4.7 % +77.5 % 94 42 5.1 % 5.4 % 1.58 — 29.9 8.8 — — — -2.6 -39.8 % 90.9 % -51.7 % -1,481.3 % -18.1 % — -49.0 % +21.5 % 4 0.0 % 0.0 % -8.0 100.6 % 11.7 % 4.6 (8)
SEPN Septerna, Inc. 08/10 — 65 % Stage 2 B 58 4 of 9 2.0 $ Biotechnology – — — Healthcare 43.70 $ +31.2 % +17.9 % +109.7 % −9.1 % +23.2 % 94 50 7.5 % 6.9 % 2.28 — 107.5 20.0 — 18.8 — 0.0 — 100.0 % -24.5 % -9.3 % -7.1 % — — +4,174.5 % 5 0.0 % 0.0 % 7.0 102.7 % 14.4 % 4.9 (10)
DSGN Design Therapeutics Inc 08/06 +47 % 72 % Stage 2 D 38 1 of 9 0.6 $ Biotechnology – — — Healthcare 10.30 $ +46.5 % +46.2 % +51.5 % −22.1 % +102.9 % 94 50 7.3 % 7.9 % 1.69 — 0.0 — — — — -0.8 — -178,124.2 % 0.0 % -31.3 % -22.5 % — — -100.0 % 4 0.0 % 0.0 % 21.4 62.1 % 14.1 % 4.8 (8)
STRZ Starz Entertainment LLC — — 67 % Stage 2 D 30 4 of 9 0.4 $ Entertainment – — — Communication Services 23.40 $ +143.2 % +152.5 % +110.2 % −9.7 % +68.4 % 94 50 6.8 % 7.1 % — — 3.6 0.3 — 17.7 — 1.4 — 54.1 % -25.1 % -34.7 % -0.8 % — — -8.2 % 5 0.0 % 0.0 % 1.3 92.3 % 4.7 % 4.0 (10)
TMCI Treace Medical Concepts Inc 08/06 -28 % ⚠ Wildest 10% 90 % Stage 3 D 39 4 of 9 0.2 $ Medical Devices Neutral
Read
— Healthcare 4.30 $ +83.3 % +75.0 % -33.2 % −42.8 % +19.6 % 94 42 10.5 % 9.8 % 1.49 — 0.0 1.2 3.4 — — -40.9 — 79.5 % -29.0 % -66.9 % -17.3 % 0.18 — +1.6 % 3 0.0 % 0.0 % 0.4 57.1 % 3.8 % 3.2 (5)
ACRS Aclaris Therapeutics Inc 08/06 -17 % ⚠ Wildest 10% 88 % Stage 2 D 27 5 of 9 0.5 $ Biotechnology – — — Healthcare 3.70 $ +63.5 % +65.1 % +50.8 % −4.7 % +156.8 % 94 42 5.9 % 5.5 % 0.88 — 0.0 62.4 — — — 0.3 — -757.7 % 0.0 % -48.4 % -29.0 % — — -58.2 % 3 0.0 % 0.0 % -9.9 79.7 % 11.6 % 4.8 (12)
AVR Anteris Technologies Global Corp. 08/10 — 61 % Stage 2 C 46 4 of 9 0.5 $ Medical Instruments & Supplies – — — Healthcare 5.60 $ +106.0 % +80.8 % +28.7 % −6.4 % +129.5 % 94 42 6.4 % 6.9 % 0.73 — 0.0 249.1 — — — 0.0 — 75.0 % 0.0 % -59.2 % -42.5 % — — -29.2 % 5 0.0 % 0.0 % 20.7 66.1 % 9.8 % 4.6 (5)
LCUT Lifetime Brands Inc 08/06 +27 % 80 % Stage 2 C 52 5 of 9 0.2 $ Furnishings, Fixtures & Appliances – — — Consumer Cyclical 8.50 $ +117.0 % +138.9 % +166.3 % −14.7 % +48.8 % 94 86 9.0 % 9.0 % 1.00 — 7.8 0.3 — 9.4 0.56 5.7 — 37.3 % 4.8 % -13.0 % 2.6 % — — -5.1 % 4 2.1 % 7.1 % 6.0 68.2 % 11.0 % 5.0 (1)
RCUS Arcus Biosciences Inc 08/05 +16 % 62 % Stage 2 D 33 0 of 9 2.4 $ Biotechnology Neutral
Read
— Healthcare 18.90 $ +18.3 % +34.4 % -9.5 % −3.8 % +122.8 % 93 42 6.2 % 6.0 % 0.94 — 0.0 20.3 5.8 — — 4.0 -788.2 % -324.8 % 0.0 % -70.0 % -30.4 % 0.22 52.6 % -4.3 % 4 0.0 % 0.0 % 1.0 72.4 % 16.8 % 4.7 (15)
TSHA Taysha Gene Therapies Inc 08/11 +87 % 71 % Stage 2 D 32 4 of 9 1.2 $ Biotechnology Neutral
Read
— Healthcare 4.10 $ +24.7 % +13.9 % -19.4 % −14.9 % +217.1 % 93 50 7.2 % 6.9 % 1.17 — 0.0 214.2 — — — -0.6 -1,774.4 % 100.0 % 0.0 % -97.3 % -23.8 % — 70.6 % +17.3 % 6 0.0 % 0.0 % 0.4 95.8 % 16.0 % 4.8 (13)
CORZ Core Scientific, Inc. 08/14 — 73 % Stage 2 C 45 4 of 9 4.5 $ Software - Infrastructure – — — Technology 14.20 $ +100.3 % +66.6 % -42.0 % −10.5 % +109.8 % 93 80 6.3 % 6.5 % 5.48 — 22.9 10.2 0.0 — — 454.9 -18.8 % 32.1 % 0.0 % 0.0 % -2.4 % -1.57 -42.5 % -37.5 % 4 0.0 % 0.0 % -5.1 124.5 % 23.2 % 4.7 (22)
GSAT Globalstar, Inc. 08/06 +150 % 51 % Stage 2 D 34 5 of 9 10.8 $ Telecom Services – — — Communication Services 83.80 $ +30.9 % +28.3 % +52.4 % −5.6 % +7.3 % 93 42 1.5 % 1.5 % 1.45 — 9.2 38.5 31.4 160.9 0.50 117.8 16.3 % 62.3 % -18.5 % -2.5 % 0.4 % 1.54 14.4 % +9.0 % 9 0.0 % 0.0 % 1.0 26.3 % 7.9 % 3.7 (3)
EWTX Edgewise Therapeutics Inc 08/06 +137 % 71 % Stage 2 D 26 3 of 9 3.8 $ Biotechnology – — — Healthcare 37.70 $ +56.5 % +49.9 % +108.5 % −5.1 % +29.9 % 93 42 7.6 % 6.7 % 0.36 — 0.0 — 8.4 — — -2.6 0.0 % — 0.0 % -38.1 % -25.0 % 0.01 95.1 % — 2 0.0 % 0.0 % 23.8 113.9 % 15.3 % 4.5 (14)
LASR nLIGHT Inc 08/06 +113 % ⚠ Wildest 10% 87 % Stage 2 B 74 7 of 9 2.1 $ Semiconductors – — — Technology 36.50 $ +77.1 % +65.4 % +8.4 % −28.2 % +113.3 % 93 42 7.4 % 8.0 % 2.37 — 54.6 6.6 4.5 49.5 1.78 558.5 -0.5 % 31.5 % -4.0 % -4.6 % -2.2 % 0.08 83.2 % +31.6 % 4 0.0 % 0.0 % 11.0 92.1 % 4.9 % 4.9 (9)
CGEM Cullinan Oncology LLC 08/06 +14 % 76 % Stage 2 C 50 1 of 9 1.0 $ Biotechnology – — — Healthcare 15.80 $ +71.5 % +79.5 % +72.4 % −1.5 % +121.8 % 93 42 8.3 % 8.2 % -0.04 — 6.7 — — — — -1.5 — — 0.0 % -48.2 % -31.4 % — — -100.0 % 3 0.0 % 0.0 % 10.2 107.8 % 16.5 % 4.9 (12)
JBIO Jade Biosciences, Inc. 08/12 -21 % 72 % Stage 2 D 35 2 of 9 0.8 $ Biotechnology – — — Healthcare 14.60 $ +42.4 % +33.8 % +42.1 % −22.1 % +243.3 % 93 42 9.6 % 9.1 % — — 0.0 — 3.0 — — 0.0 — — 0.0 % -89.2 % -33.6 % 0.00 — — 2 0.0 % 0.0 % 18.0 84.8 % 23.3 % 5.0 (10)
CLDT Chatham Lodging Trust REIT 08/05 +22 % 30 % Stage 2 C 46 5 of 9 0.7 $ REIT - Hotel & Motel – — — Real Estate 15.00 $ +100.8 % +98.8 % +144.3 % −2.2 % -1.4 % 93 19 3.5 % 3.0 % 1.13 769.6 238.1 2.5 1.0 9.6 2.28 11.5 — 49.1 % 4.0 % 1.2 % 1.6 % 0.61 — -7.0 % 4 2.7 % 97.5 % 4.1 97.8 % 2.7 % 4.0 (4)
MRVI Maravai Lifesciences Holdings Inc 08/10 -20 % 68 % Stage 2 B 61 5 of 9 2.7 $ Biotechnology – — — Healthcare 7.50 $ +65.2 % +93.6 % +129.0 % −1.6 % +0.0 % 93 19 5.9 % 5.5 % 0.54 — 370.4 13.0 4.9 — — 1.8 — 35.7 % -37.1 % -41.0 % -5.7 % 1.28 — -28.3 % 2 0.0 % 0.0 % 4.3 88.5 % 11.0 % 4.1 (9)
WEST Westrock Coffee Company 08/06 -6 % 64 % Stage 2 C 50 3 of 9 0.9 $ Packaged Foods – — — Consumer Defensive 9.50 $ +123.1 % +98.3 % +120.0 % −2.4 % +1.0 % 93 50 7.4 % 6.7 % 0.89 — 0.0 0.7 — — — 36.8 — 12.5 % -4.9 % -24.0 % -0.1 % — — +39.8 % 3 0.0 % 0.0 % 1.8 49.5 % 15.4 % 5.0 (4)
FATE Fate Therapeutics Inc 08/11 -19 % ⚠ Wildest 10% 86 % Stage 2 D 37 2 of 9 0.2 $ Biotechnology Neutral
Read
— Healthcare 2.00 $ +119.8 % +139.6 % +48.9 % −35.1 % +173.5 % 93 42 12.1 % 11.5 % 2.53 — 0.0 35.5 — — — -2.6 — -1,200.6 % 0.0 % -55.5 % -26.2 % — — -51.2 % 2 0.0 % 0.0 % -12.5 72.8 % 10.1 % 3.8 (11)
CCCC C4 Therapeutics Inc 08/06 -23 % 80 % Stage 2 C 47 4 of 9 0.4 $ Biotechnology – — — Healthcare 3.20 $ +120.9 % +109.1 % +23.0 % −4.3 % +328.6 % 93 42 7.7 % 9.3 % 3.08 — 0.0 10.4 1.5 — — -0.4 — 86.3 % -289.4 % -48.4 % -19.3 % 0.25 — +1.0 % 3 0.0 % 0.0 % 0.5 85.1 % 33.0 % 4.8 (8)
FTRE Fortrea Holdings Inc. 08/05 -17 % 71 % Stage 2 C 48 4 of 9 1.9 $ Biotechnology Uses AI
Read
— Healthcare 21.00 $ -4.6 % -1.0 % +91.4 % −5.1 % -16.2 % 92 13 6.2 % 6.3 % 1.91 — 12.2 0.7 — 10.1 0.34 38.0 0.5 % 19.3 % -3.2 % -64.6 % 0.6 % — 19.6 % +1.0 % 3 0.0 % 0.0 % 0.8 110.4 % 15.5 % 3.9 (13)
GH Guardant Health Inc 07/29 +89 % 51 % Stage 2 B 55 6 of 9 23.2 $ Diagnostics & Research Sells AI
Read
— Healthcare 175.00 $ +28.1 % +50.2 % +76.9 % −2.0 % +13.2 % 92 42 5.3 % 5.7 % 1.58 — 0.0 19.6 67.4 — — -5.4 -40.2 % 65.0 % -38.3 % -4,584.5 % -18.1 % -6.60 -9.5 % +32.9 % 3 0.0 % 0.0 % 0.1 106.0 % 9.3 % 4.7 (26)
INSW International Seaways Inc 08/05 +79 % 40 % Stage 2 B 69 7 of 9 5.1 $ Oil & Gas Midstream Neutral
Read
— Energy 104.80 $ +102.2 % +76.8 % +140.5 % −12.1 % +12.8 % 92 95 5.0 % 4.2 % -0.10 — 16.9 4.1 — 15.9 — 6.2 61.3 % 72.5 % 61.8 % 26.9 % 15.8 % — 76.4 % -11.4 % 5 7.2 % 94.0 % 11.0 80.8 % 9.5 % 4.7 (6)
MRX Marex Group plc 08/12 — 45 % Stage 2 B 62 4 of 9 4.8 $ Capital Markets – — — Financial Services 68.40 $ +74.6 % +49.3 % +116.8 % −4.8 % +23.5 % 92 79 4.9 % 4.7 % -0.02 15.4 7.2 0.9 3.6 — — 5.6 13.1 % 70.1 % 12.2 % 29.1 % 1.1 % — 3.7 % +25.4 % 8 0.9 % 11.9 % 4.2 75.2 % 3.9 % 4.4 (9)
NAT Nordic American Tankers Limited — +50 % 41 % Stage 2 B 67 4 of 9 1.6 $ Oil & Gas Midstream Neutral
Read
— Energy 7.40 $ — — +129.3 % −0.7 % +6.3 % 92 97 5.9 % 4.4 % -0.52 26.5 14.0 4.7 3.2 — 1.21 12.3 49.5 % 53.2 % 33.3 % 11.4 % 7.2 % 0.95 49.4 % -16.4 % 3 13.7 % 1.7 % 2.5 56.7 % 7.7 % 3.0 (2)
ETON Eton Pharmaceuticals Inc 08/06 +249 % 67 % Stage 2 B 63 7 of 9 1.4 $ Drug Manufacturers - Specialty & Generic – — — Healthcare 51.00 $ +98.0 % +116.2 % +182.1 % −2.4 % +38.0 % 92 26 4.8 % 5.7 % 0.90 — 21.6 13.3 47.5 95.9 — 68.9 — 61.4 % 12.0 % -5.4 % 11.9 % 0.40 — +104.9 % 8 0.0 % 0.0 % 0.7 65.4 % 8.9 % 5.0 (4)
RAPP Rapport Therapeutics, Inc. 08/06 — 63 % Stage 2 D 29 4 of 9 1.2 $ Biotechnology Neutral
Read
— Healthcare 25.40 $ +28.1 % +30.6 % -13.1 % −8.0 % +203.5 % 92 42 6.0 % 6.1 % 1.22 — 0.0 59.8 3.1 — — 0.0 — -109.4 % 0.0 % -28.3 % -25.8 % 0.02 — — 2 0.0 % 0.0 % 25.1 109.6 % 10.5 % 4.9 (16)
BCAX Bicara Therapeutics Inc. 08/11 — 81 % Stage 2 D 29 1 of 9 0.6 $ Biotechnology – — — Healthcare 9.00 $ +48.5 % +69.9 % -51.2 % −5.8 % +263.9 % 92 42 6.8 % 5.8 % -0.69 — 0.0 — 1.2 — — 0.0 — — 0.0 % -32.3 % -26.1 % 0.00 — — 4 0.0 % 0.0 % 18.5 104.3 % 22.5 % 4.6 (14)
ULCC Frontier Group Holdings Inc 08/04 -7 % 78 % Stage 2 C 51 3 of 9 1.5 $ Airlines – — — Industrials 6.50 $ +53.9 % +55.0 % +92.5 % −4.1 % +2.2 % 92 52 7.3 % 7.6 % 2.65 — 9.8 0.3 6.2 13.9 — 100.0 — 0.5 % -9.3 % -92.4 % -5.3 % 23.64 — -1.4 % 4 0.0 % 0.0 % 1.7 55.2 % 40.1 % 2.8 (12)
IMUX Immunic Inc 08/06 +0 % 82 % Stage 2 D 42 5 of 9 0.1 $ Biotechnology – — — Healthcare 7.60 $ +182.2 % +163.9 % -5.8 % −4.4 % +467.0 % 92 42 6.7 % 8.8 % 1.45 — 0.0 — — — — 0.2 — — 0.0 % -142.9 % -66.8 % — — -100.0 % — 0.0 % 0.0 % -2.1 46.9 % 16.1 % 5.0 (12)
ROIV Roivant Sciences Ltd 08/10 +76 % 45 % Stage 2 D 39 3 of 9 25.2 $ Biotechnology Uses AI — — Healthcare 36.00 $ +48.4 % +54.4 % +79.5 % −1.9 % +34.0 % 91 2 3.9 % 4.0 % 1.10 — 0.0 3,357.6 5.3 — — 0.7 -14,675.1 % -9,610.9 % 0.0 % -7.6 % -16.3 % 0.02 79.0 % -71.6 % 5 0.0 % 0.0 % 19.2 75.9 % 7.4 % 4.5 (13)
TIGO Millicom International Cellular SA 08/06 +180 % 42 % Stage 2 B 63 4 of 9 13.1 $ Telecom Services Neutral
Read
— Communication Services 77.50 $ +64.9 % +77.5 % +73.7 % −6.6 % +20.8 % 91 17 4.6 % 4.5 % 0.90 10.8 8.5 2.0 4.2 9.4 0.27 7.1 21.8 % 76.6 % 9.2 % 37.4 % 5.9 % 3.74 15.1 % +0.3 % 4 3.8 % 109.3 % 4.0 46.2 % 2.8 % 3.1 (8)
KGS Kodiak Gas Services, Inc. 08/05 — 43 % Stage 2 B 58 7 of 9 4.6 $ Oil & Gas Equipment & Services – — — Energy 46.50 $ +94.9 % +106.1 % +25.2 % −4.8 % +65.3 % 91 17 4.1 % 3.8 % 0.94 56.8 17.4 3.3 3.9 927.0 — 12.1 33.7 % 63.8 % 5.8 % 5.4 % 5.9 % 0.06 26.1 % +12.8 % 7 4.3 % 118.8 % 4.2 91.3 % 10.4 % 4.7 (15)
DHC Diversified Healthcare Trust 08/03 +127 % 38 % Stage 2 C 51 4 of 9 1.8 $ REIT - Healthcare Facilities Uses AI — — Real Estate 7.60 $ +89.0 % +97.1 % +82.7 % −0.5 % +30.1 % 91 9 4.3 % 4.0 % 2.27 — 16.6 1.2 1.2 33.3 1.89 33.3 -1.3 % 18.6 % -17.7 % -17.9 % -0.4 % 1.49 38.0 % +2.8 % 3 0.5 % 2.3 % 1.6 84.3 % 5.4 % 4.0 (5)
GHM Graham Corporation 08/04 +251 % 54 % Stage 2 C 52 1 of 9 0.9 $ Specialty Industrial Machinery – — — Industrials 73.90 $ +70.9 % +69.7 % +13.5 % −1.0 % +79.4 % 91 50 6.2 % 6.7 % 1.08 — 36.6 3.3 — — 2.03 34.5 1.3 % 23.4 % 4.5 % 9.6 % 3.2 % — 43.4 % +16.9 % 6 0.0 % 0.0 % 5.4 80.2 % 9.6 % 4.3 (6)
LIND Lindblad Expeditions Holdings Inc 08/03 +50 % 50 % Stage 2 B 65 8 of 9 2.2 $ Travel Services – — — Consumer Cyclical 32.80 $ +78.7 % +94.4 % +204.0 % −1.1 % +0.6 % 91 94 5.8 % 5.4 % 2.24 — 59.2 2.6 191.9 17.9 — 25.0 7.5 % 46.7 % -2.1 % -1,946.9 % 4.1 % -3.50 -19.3 % +19.6 % 6 0.0 % 0.0 % 1.3 75.0 % 11.7 % 4.3 (6)
OMER Omeros Corporation 08/13 -8 % ⚠ Wildest 10% 98 % Stage 1 B 70 6 of 9 1.3 $ Biotechnology – — — Healthcare 18.30 $ -39.0 % -35.5 % +143.3 % −39.3 % +53.6 % 91 42 10.1 % 8.1 % 2.57 12.5 68.0 34.7 13.8 — 0.81 126.9 — 38.3 % 324.9 % -576.3 % -18.7 % -4.91 — -100.0 % 3 0.0 % 0.0 % -1.8 44.5 % 16.3 % 4.3 (3)
ARMP Armata Pharmaceuticals Inc 08/11 +51 % ⚠ Wildest 10% 112 % Stage 1 D 35 4 of 9 0.1 $ Biotechnology Neutral — — Healthcare 3.10 $ +11.6 % +0.8 % -42.0 % −60.2 % +400.0 % 91 42 11.0 % 10.5 % 1.41 — 0.0 — — — — 14.4 — -217.4 % 0.0 % -3,439.4 % -25.8 % — — -5.2 % 3 0.0 % 0.0 % -52.2 10.5 % 8.6 % 4.0 (1)
AVTX Avalo Therapeutics Inc 08/06 -33 % ⚠ Wildest 10% 93 % Stage 3 E 20 2 of 9 0.4 $ Biotechnology – — — Healthcare 7.30 $ -1.8 % +2.0 % -59.4 % −25.8 % +415.5 % 91 42 7.7 % 7.4 % 0.70 — 0.0 — — — — -0.2 — -81,174.6 % 0.0 % -88.8 % -18.5 % — — -86.6 % 2 0.0 % 0.0 % -10.4 76.6 % 22.3 % 4.9 (14)
ESOA Energy Services Of America Corp 08/10 +201 % 59 % Stage 2 B 65 9 of 9 0.2 $ Engineering & Construction Neutral — — Industrials 9.30 $ +126.3 % +137.4 % -16.6 % −6.2 % +166.0 % 91 91 5.3 % 5.4 % 1.29 16.9 10.6 0.4 2.1 32.0 — 6.3 — 11.8 % 2.2 % 13.7 % 5.5 % 0.46 — +16.8 % 4 1.7 % 23.3 % 5.7 55.5 % 3.8 % 5.0 (3)
ALKS Alkermes Plc 08/04 +15 % 40 % Stage 2 C 53 1 of 9 7.6 $ Drug Manufacturers - Specialty & Generic – — — Healthcare 45.70 $ +71.8 % +84.2 % +46.2 % −1.6 % +24.1 % 90 9 4.8 % 4.2 % 0.27 54.0 133.3 4.6 4.6 34.3 1.96 38.4 -0.2 % 87.2 % 4.0 % 9.4 % 4.2 % 0.90 41.1 % -5.3 % 5 0.0 % 0.0 % 4.9 110.5 % 14.7 % 4.3 (20)
INDV Indivior Pharmaceuticals, Inc. 07/30 +25 % 33 % Stage 2 B 69 4 of 9 4.1 $ Drug Manufacturers - Specialty & Generic Neutral
Read
— Healthcare 36.40 $ +11.4 % +14.1 % +23.5 % −1.9 % +40.8 % 90 83 3.6 % 3.6 % 1.18 19.2 9.0 3.0 129.9 133.0 — 10.0 46.1 % 85.7 % 26.8 % 12.2 % 26.4 % -3.49 -12.0 % +4.3 % 4 0.0 % 2.2 % 3.6 107.5 % 10.5 % 4.8 (4)
ATEN A10 Networks, Inc. 08/04 +48 % 40 % Stage 2 B 63 7 of 9 1.8 $ Software - Infrastructure – — — Technology 24.30 $ +92.3 % +102.9 % +33.3 % −1.3 % +35.8 % 90 71 4.1 % 4.3 % 1.12 — 22.4 5.7 — 28.8 14.76 21.8 17.3 % 79.4 % 13.9 % 21.4 % 5.0 % — 34.8 % +11.0 % 5 0.9 % 27.3 % 7.7 103.9 % 19.1 % 4.2 (6)
IOVA Iovance Biotherapeutics Inc 08/06 -15 % ⚠ Wildest 10% 109 % Stage 2 B 61 5 of 9 3.8 $ Biotechnology Neutral
Read
— Healthcare 8.80 $ +62.6 % +46.7 % +307.1 % −25.2 % -2.7 % 90 42 7.9 % 8.3 % 0.76 — 0.0 11.6 — — — -8.7 — 48.4 % -89.1 % -47.5 % -20.3 % — — +60.6 % 4 0.0 % 0.0 % -3.3 67.5 % 13.9 % 4.4 (10)
PAYS Paysign Inc 08/04 +67 % 66 % Stage 2 A 78 6 of 9 0.9 $ Software - Infrastructure Neutral — — Technology 15.10 $ +44.5 % +55.2 % +178.5 % −13.1 % +0.7 % 90 84 5.4 % 5.9 % 0.83 — 33.1 8.5 — 12.3 — 29.6 — 61.0 % 15.7 % 22.1 % 4.3 % — — +40.5 % 9 0.0 % 0.0 % 4.6 47.3 % 5.1 % 4.6 (5)
CLPT Clearpoint Neuro Inc 08/11 +61 % ⚠ Wildest 10% 87 % Stage 3 D 40 4 of 9 0.3 $ Medical Devices Neutral — — Healthcare 9.70 $ +35.5 % +34.1 % -57.2 % −40.3 % +161.1 % 90 42 11.6 % 9.0 % 1.29 — 12.1 6.4 16.3 — 0.61 -7.1 — 62.6 % -81.8 % -149.7 % -24.4 % 3.38 — +17.8 % 3 0.0 % 0.0 % -3.1 50.6 % 16.2 % 5.0 (2)
ATLC Atlanticus Holdings Corporation 08/06 +51 % 52 % Stage 2 B 70 6 of 9 1.4 $ Credit Services Uses AI
Read
— Financial Services 92.50 $ +51.4 % +49.6 % +69.0 % −2.8 % +42.6 % 90 77 6.3 % 6.0 % 1.99 — 7.9 0.7 — 1.5 — 0.0 — 73.0 % 21.1 % 21.4 % 2.8 % — — +53.3 % 7 0.0 % 0.0 % 4.5 25.0 % 28.2 % 4.8 (5)
FSTR LB Foster Company 08/10 +74 % 37 % Stage 2 B 56 6 of 9 0.4 $ Railroads – — — Industrials 36.50 $ +63.0 % +59.5 % +33.9 % −2.6 % +25.0 % 90 4 3.9 % 4.2 % 1.14 35.1 17.3 0.7 2.2 9.2 0.48 12.7 — 21.9 % 2.0 % 6.4 % 5.3 % 0.48 — +1.7 % 5 0.0 % 0.0 % 8.4 72.3 % 4.9 % 3.0 (1)
HSHP Himalaya Shipping Ltd. 08/14 +61 % 43 % Stage 2 B 64 7 of 9 0.7 $ Marine Shipping – — — Industrials 15.40 $ +71.0 % +58.7 % +123.5 % −17.9 % +0.0 % 90 97 4.0 % 3.9 % 0.93 — 9.1 5.1 — 12.0 — 10.9 — 81.6 % 31.4 % 18.3 % 7.4 % — — +6.7 % 7 20.1 % 86.6 % 4.3 47.7 % 4.8 % 4.0 (1)
MG Mistras Group Inc 08/05 +56 % 44 % Stage 2 C 53 8 of 9 0.6 $ Security & Protection Services – — — Industrials 20.20 $ +50.8 % +38.6 % +111.2 % −4.4 % +13.9 % 90 21 3.7 % 3.8 % 0.91 — 15.9 0.9 — 20.0 1.00 10.3 — 31.6 % 3.7 % 10.4 % 6.4 % — — -0.8 % 5 0.0 % 0.0 % 5.6 62.5 % 5.9 % 5.0 (1)
NNBR NN Inc 08/05 +11 % ⚠ Wildest 10% 86 % Stage 2 C 51 3 of 9 0.2 $ Conglomerates – — — Industrials 3.70 $ +125.0 % +204.2 % +117.5 % −17.3 % +90.5 % 90 42 12.4 % 9.4 % 2.66 — 14.3 0.4 7.7 93.3 0.83 21.1 — 15.1 % -6.2 % -21.9 % -1.8 % 1.52 — -9.1 % 3 0.0 % 93.3 % 2.0 56.5 % 4.5 % 5.0 (3)
SPIR Spire Global Inc 08/12 +124 % ⚠ Wildest 10% 100 % Stage 2 C 48 4 of 9 0.3 $ Specialty Business Services Sells AI — — Industrials 8.70 $ +132.5 % +114.7 % -21.5 % −38.3 % +129.4 % 90 42 9.1 % 11.1 % 2.81 5.3 0.0 5.5 3.7 — — 7.8 — 37.9 % -145.2 % 101.2 % -22.0 % 0.13 — -35.2 % 4 0.0 % 0.0 % -8.1 39.9 % 10.3 % 5.0 (4)
ZURA Zura Bio Limited 08/13 -21 % 82 % Stage 1 D 36 3 of 9 0.4 $ Biotechnology – — — Healthcare 4.00 $ -17.8 % +25.1 % +2.6 % −39.0 % +427.8 % 90 42 9.7 % 8.0 % 0.01 — 0.0 — — — — -2.3 — — 0.0 % -41.0 % -31.2 % — — — 3 0.0 % 0.0 % 23.1 78.6 % 13.1 % 4.9 (7)
LGND Ligand Pharmaceuticals Incorporated 08/06 +94 % 37 % Stage 2 B 56 5 of 9 5.9 $ Biotechnology – — — Healthcare 313.50 $ +47.8 % +59.3 % +60.5 % −1.4 % +8.5 % 89 86 5.6 % 4.1 % 1.01 41.2 25.1 23.2 6.4 65.1 1.53 21.3 33.6 % 81.2 % 67.9 % 17.1 % 4.0 % 0.51 65.1 % +60.4 % 7 0.0 % 0.0 % 10.8 106.4 % 16.1 % 4.7 (11)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

Minervini/Qullamaggie Power Trend: the daily low has stayed above the 21-day EMA for at least 10 days, the 21-EMA has been above the 50-day SMA for at least 5 days, and the 50-SMA is rising — the condition in which trend traders are fully invested. When the Power Trend ends, they reduce risk.

All scanners are recalculated daily across the entire stock universe — most recently on November 4, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 1667 stocks pass this scanner's criteria (as of November 4, 2026). The 100 strongest hits are shown.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?